172 related articles for article (PubMed ID: 7778292)
21. Human immunodeficiency virus long terminal repeat responds to transformation by the mutant T24 H-ras1 oncogene and it contains multiple AP-1 binding TPA-inducible consensus sequence elements.
Spandidos DA; Yiagnisis M; Pintzas A
Anticancer Res; 1989; 9(2):383-6. PubMed ID: 2665635
[TBL] [Abstract][Full Text] [Related]
22. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.
Thompson FJ; Elder J; Neil JC
J Gen Virol; 1994 Mar; 75 ( Pt 3)():545-54. PubMed ID: 8126451
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 tat trans-activation requires the loop sequence within tar.
Feng S; Holland EC
Nature; 1988 Jul; 334(6178):165-7. PubMed ID: 3386755
[TBL] [Abstract][Full Text] [Related]
24. Protein-binding properties of the putative AP-1 and ATF sequences in the feline immunodeficiency virus long terminal repeat.
Ikeda Y; Inoshima Y; Kawaguchi Y; Maeda K; Kohmoto M; Kai C; Miyazawa T; Mikami T
J Gen Virol; 1998 Jan; 79 ( Pt 1)():95-9. PubMed ID: 9460929
[TBL] [Abstract][Full Text] [Related]
25. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
[TBL] [Abstract][Full Text] [Related]
26. Activation of bovine immunodeficiency-like virus expression by bovine herpesvirus type 1.
Geng Y; Kashanchi F; Wood C
Virology; 1992 Apr; 187(2):832-6. PubMed ID: 1312280
[TBL] [Abstract][Full Text] [Related]
27. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
Maciaszek JW; Talmage DA; Viglianti GA
J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
[TBL] [Abstract][Full Text] [Related]
28. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.
Zeichner SL; Kim JY; Alwine JC
J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.
Jeang KT; Chun R; Lin NH; Gatignol A; Glabe CG; Fan H
J Virol; 1993 Oct; 67(10):6224-33. PubMed ID: 7690421
[TBL] [Abstract][Full Text] [Related]
30. Conditional regulatory elements of human immunodeficiency virus type 2 long terminal repeat.
Arya SK; Mohr JR
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2253-60. PubMed ID: 8077923
[TBL] [Abstract][Full Text] [Related]
31. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
[TBL] [Abstract][Full Text] [Related]
32. Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.
Bigornia L; Lockridge KM; Sparger EE
J Virol; 2001 Jan; 75(2):1054-60. PubMed ID: 11134320
[TBL] [Abstract][Full Text] [Related]
33. Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression.
Perkins ND; Agranoff AB; Duckett CS; Nabel GJ
J Virol; 1994 Oct; 68(10):6820-3. PubMed ID: 8084021
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
Duh EJ; Maury WJ; Folks TM; Fauci AS; Rabson AB
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5974-8. PubMed ID: 2762307
[TBL] [Abstract][Full Text] [Related]
35. Comparative functional analysis of Jembrana disease virus Tat protein on lentivirus long terminal repeat promoters: evidence for flexibility at its N-terminus.
Su Y; Deng G; Gai Y; Li Y; Gao Y; Du J; Geng Y; Chen Q; Qiao W
Virol J; 2009 Oct; 6():179. PubMed ID: 19860923
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor AP-4 participates in activation of bovine leukemia virus long terminal repeat by p34 Tax.
Unk I; Kiss-Toth E; Boros I
Nucleic Acids Res; 1994 Nov; 22(23):4872-5. PubMed ID: 7800474
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning of biologically active proviruses of bovine immunodeficiency-like virus.
Braun MJ; Lahn S; Boyd AL; Kost TA; Nagashima K; Gonda MA
Virology; 1988 Dec; 167(2):515-23. PubMed ID: 2462309
[TBL] [Abstract][Full Text] [Related]
38. Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.
Parrott C; Seidner T; Duh E; Leonard J; Theodore TS; Buckler-White A; Martin MA; Rabson AB
J Virol; 1991 Mar; 65(3):1414-9. PubMed ID: 1995951
[TBL] [Abstract][Full Text] [Related]
39. The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression.
Adam E; Kerkhofs P; Mammerickx M; Burny A; Kettmann R; Willems L
J Virol; 1996 Mar; 70(3):1990-9. PubMed ID: 8627725
[TBL] [Abstract][Full Text] [Related]
40. Identification of two human sequence-specific DNA-binding proteins which interact with the direct repeats in the squirrel monkey retrovirus long terminal repeat.
Ikeda S; Watanabe T; Oda T
Virology; 1995 Aug; 211(1):316-9. PubMed ID: 7645228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
